IEQ Capital’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.8K Buy
41,357
+31,293
+311% +$67.9K ﹤0.01% 1820
2025
Q4
$23.6K Sell
10,064
-31,443
-76% -$85.9K ﹤0.01% 1822
2025
Q3
$127K Buy
41,507
+31,293
+306% +$89.4K ﹤0.01% 1742
2025
Q2
$28.5K Hold
10,214
﹤0.01% 1788
2025
Q1
$36.7K Hold
10,214
﹤0.01% 1568
2024
Q4
$32.2K Hold
10,214
﹤0.01% 1307
2024
Q3
$28.8K Hold
10,214
﹤0.01% 1142
2024
Q2
$12.6K Hold
10,214
﹤0.01% 998
2024
Q1
$8.11K Hold
10,214
﹤0.01% 969
2023
Q4
$9.72K Sell
10,214
-2,850
-22% -$2.8K ﹤0.01% 922
2023
Q3
$14.1K Buy
+13,064
New +$15.5K ﹤0.01% 935
2022
Q3
Sell
-17,193
Closed -$37K 844
2022
Q2
$37K Sell
17,193
-273
-2% -$726 ﹤0.01% 788
2022
Q1
$62K Buy
+17,466
New +$50.6K ﹤0.01% 799
2021
Q4
Sell
-11,564
Closed -$85K 728
2021
Q3
$85K Buy
+11,564
New +$98.9K ﹤0.01% 680

Other funds holding CLOV

IEQ Capital's CLOV Position: Q1 2026 in Review

IEQ Capital increased its Clover Health Investments (CLOV) stake by 311% in Q1 2026, buying an estimated $67.9K and bringing the position to 41,357 shares worth $72.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1820.

IEQ Capital first reported a position in CLOV in Q3 2021 and has held it in 14 quarters since. The position peaked at $127K in Q3 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • IEQ Capital held 41,357 shares of Clover Health Investments worth $72.8K as of Q1 2026.
  • IEQ Capital bought 31,293 Clover Health Investments shares in Q1 2026, an estimated $67.9K.
  • Clover Health Investments made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1820 holding.
  • IEQ Capital first reported a position in Clover Health Investments in Q3 2021 and has held it in 14 quarters since.
  • IEQ Capital's Clover Health Investments position peaked at $127K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.